PDX Select
Model Bank
Search through our extensive and highly characterized PDX bank.
1393 models
page 58 of 59
CTG-4354
Lymphoma
Pending
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Parotid Gland
Disease stage
I
Lumin data
RNA-Seq, WES
View model →
CTG-4356
Lymphoma
Pending
Tumor status
Pending
Treatment history
Pending
Harvest site
Pending
Disease stage
Pending
Lumin data
RNA-Seq, WES
View model →
CTG-4358
Lymphoma
Germinal center B cell (GCB)
Tumor status
Pending
Treatment history
Pretreated
Harvest site
Lymph Node
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4363
NSCLC
Adenocarcinoma
Tumor status
Local metastatic
Treatment history
Pretreated
Harvest site
Lung
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4365
Breast
Invasive ductal carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4379
Breast
Invasive ductal carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Liver
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4382
Lymphoma
Germinal center B cell (GCB)
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Chest Wall
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4387
Lymphoma
Not available
Tumor status
Metastatic
Treatment history
Naive
Harvest site
Pleural Fluid
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4388
Lymphoma
EBV+ Extranodal NK/T-cell Lymphoma
Tumor status
Not available
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (CTC)
Disease stage
II
View model →
CTG-4399
Ovarian
High grade serous carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Ascites
Disease stage
IV
View model →
CTG-4401
Breast
Invasive Lobular Carcinoma (ILC)
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Mesentery
Disease stage
IV
View model →
CTG-4403
SCLC
Small cell carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (CTC)
Disease stage
Not Available
Lumin data
RNA-Seq, WES
View model →
CTG-4404
SCLC
Small cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Lung
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4405
SCLC
Small cell carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (CTC)
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4406
SCLC
Small cell carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (CTC)
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4407
SCLC
Small Cell Carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Lung
Disease stage
II
View model →
CTG-4408
SCLC
Small cell carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (CTC)
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4409
SCLC
Small Cell Carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Circulating Tumor Cells (Ctc)
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4410
SCLC
Small cell carcinoma
Tumor status
Primary
Treatment history
Naive
Harvest site
Lung
Disease stage
II
Lumin data
RNA-Seq, WES
View model →
CTG-4411
SCLC
Small cell carcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Lung
Disease stage
III
Lumin data
RNA-Seq, WES
View model →
CTG-4476
Melanoma
Acral lentiginous
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Stomach
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4488
Lymphoma
View model →
CTG-4500
Bladder
Urothelial carcinoma
Tumor status
Metastatic
Treatment history
Pretreated
Harvest site
Adrenal Gland
Disease stage
IV
Lumin data
RNA-Seq, WES
View model →
CTG-4522
Breast
Invasive ductal carcinoma
Tumor status
Primary
Treatment history
Pretreated
Harvest site
Breast
Disease stage
IV
View model →
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.